[Intensive transfusion-infusion therapy of patients with cirrhosis of the liver].
Optimum programs have been developed for the differential intensive transfusion-infusion therapy of patients with cirrhosis of the liver, based on the characteristics of the clinical course of the disease and the directed action of varying current solutions. Overtime clinical investigations were conducted in 296 patients with cirrhosis of the liver. The results of the study have shown a favourable effect of the components, blood preparations and hemocorrectors on the clinical signs of the disease, on the function of the liver, kidneys, hemostasis system and microcirculation.
Zherebtsov
L A
LA
Voronina
L N
LN
Kubantseva
I V
IV
Postnikov
A A
AA
Valova
G M
GM
Korol'ko
Iu R
IuR
Doĭneko
M V
MV
Levina
A A
AA
D000293:Adolescent; D000328:Adult; D000368:Aged; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010952:Plasma Substitutes; D010956:Plasmapheresis; D011205:Povidone / Q000008:administration & dosage*
D010952:Plasma Substitutes; C007918:hemodes; D011205:Povidone
Intensivnaia transfuzionno-infuzionnaia terapiia u bol'nykh tsirrozom pecheni.